Randomized Controlled Trial

. 2015 Mar 18;5(3):e007314.

doi: 10.1136/bmjopen-2014-007314.

Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial

Affiliations

¹ Women's and Children's Health Research Institute, North Adelaide, South Australia, Australia Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia School of Paediatrics and Reproductive Health, The University of Adelaide, Adelaide, South Australia, Australia FOODplus Research Centre, The University of Adelaide, Adelaide, South Australia, Australia.
² Women's and Children's Health Research Institute, North Adelaide, South Australia, Australia Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia FOODplus Research Centre, The University of Adelaide, Adelaide, South Australia, Australia.
³ Clinical Sciences, The Murdoch Children's Research Institute, Parkville, Victoria, Australia Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia.
⁴ Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia School of Paediatrics and Reproductive Health, The University of Adelaide, Adelaide, South Australia, Australia Department of Neonatal Medicine, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
⁵ School of Population Health, The University of Adelaide, Adelaide, South Australia, Australia.
⁶ Women's and Children's Health Research Institute, North Adelaide, South Australia, Australia FOODplus Research Centre, The University of Adelaide, Adelaide, South Australia, Australia.
⁷ Clinical Sciences, The Murdoch Children's Research Institute, Parkville, Victoria, Australia Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria, Australia.
⁸ Clinical Sciences, The Murdoch Children's Research Institute, Parkville, Victoria, Australia Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria, Australia.
⁹ Centre of Neonatal Research and Education, The University of Western Australia, Perth, Western Australia, Australia King Edward Memorial Hospital and Princess Margaret Hospital for Children, Subiaco, Western Australia, Australia.
¹⁰ Perinatal Research Centre, University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
¹¹ Centre for Perinatal Medicine, Flinders Medical Centre and School of Medicine, Flinders University, Adelaide, South Australia, Australia.

PMID: 25787990
PMCID: PMC4368907
DOI: 10.1136/bmjopen-2014-007314

Randomized Controlled Trial

Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial

Carmel T Collins et al. BMJ Open. 2015.

. 2015 Mar 18;5(3):e007314.

doi: 10.1136/bmjopen-2014-007314.

Authors

Affiliations

¹ Women's and Children's Health Research Institute, North Adelaide, South Australia, Australia Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia School of Paediatrics and Reproductive Health, The University of Adelaide, Adelaide, South Australia, Australia FOODplus Research Centre, The University of Adelaide, Adelaide, South Australia, Australia.
² Women's and Children's Health Research Institute, North Adelaide, South Australia, Australia Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia FOODplus Research Centre, The University of Adelaide, Adelaide, South Australia, Australia.
³ Clinical Sciences, The Murdoch Children's Research Institute, Parkville, Victoria, Australia Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia.
⁴ Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia School of Paediatrics and Reproductive Health, The University of Adelaide, Adelaide, South Australia, Australia Department of Neonatal Medicine, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
⁵ School of Population Health, The University of Adelaide, Adelaide, South Australia, Australia.
⁶ Women's and Children's Health Research Institute, North Adelaide, South Australia, Australia FOODplus Research Centre, The University of Adelaide, Adelaide, South Australia, Australia.
⁷ Clinical Sciences, The Murdoch Children's Research Institute, Parkville, Victoria, Australia Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria, Australia.
⁸ Clinical Sciences, The Murdoch Children's Research Institute, Parkville, Victoria, Australia Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria, Australia.
⁹ Centre of Neonatal Research and Education, The University of Western Australia, Perth, Western Australia, Australia King Edward Memorial Hospital and Princess Margaret Hospital for Children, Subiaco, Western Australia, Australia.
¹⁰ Perinatal Research Centre, University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
¹¹ Centre for Perinatal Medicine, Flinders Medical Centre and School of Medicine, Flinders University, Adelaide, South Australia, Australia.

PMID: 25787990
PMCID: PMC4368907
DOI: 10.1136/bmjopen-2014-007314

Abstract

Objective: To determine if improvements in cognitive outcome detected at 18 months' corrected age (CA) in infants born <33 weeks' gestation receiving a high-docosahexaenoic acid (DHA) compared with standard-DHA diet were sustained in early childhood.

Design: Follow-up of a multicentre randomised controlled trial. Randomisation was stratified for sex, birth weight (<1250 vs ≥1250 g) and hospital.

Setting: Five Australian tertiary hospitals from 2008 to 2013.

Participants: 626 of the 657 participants randomised between 2001 and 2005 were eligible to participate.

Interventions: High-DHA (≈1% total fatty acids) enteral feeds compared with standard-DHA (≈0.3% total fatty acids) from age 2-4 days until term CA.

Primary outcome: Full Scale IQ of the Wechsler Abbreviated Scale of Intelligence (WASI) at 7 years CA. Prespecified subgroup analyses based on the randomisation strata (sex, birth weight) were conducted.

Results: 604 (92% of the 657 originally randomised) consented to participate (291 high-DHA, 313 standard-DHA). To address missing data in the 604 consenting participants (22 for primary outcome), multiple imputation was performed. The Full Scale IQ was not significantly different between groups (high-DHA 98.3, SD 14.0, standard-DHA 98.5, SD 14.9; mean difference adjusted for sex, birthweight strata and hospital -0.3, 95% CI -2.9 to 2.2; p=0.79). There were no significant differences in any secondary outcomes. In prespecified subgroup analyses, there was a significant sex by treatment interaction on measures of parent-reported executive function and behaviour. Scores were within the normal range but girls receiving the high-DHA diet scored significantly higher (poorer outcome) compared with girls receiving the standard-DHA diet.

Conclusions: Supplementing the diets of preterm infants with a DHA dose of approximately 1% total fatty acids from days 2-4 until term CA showed no evidence of benefit at 7 years' CA.

Trial registration number: Australian New Zealand Clinical Trials Registry: ACTRN12606000327583.

Keywords: NEONATOLOGY; NUTRITION & DIETETICS; PUBLIC HEALTH.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

PubMed Disclaimer

Figures

**Figure 1**
DINO trial participant flow in the 7-year follow-up. CA, corrected age; DHA, docosahexaenoic acid; DINO, Docosahexaenoic acid for the Improvement of Neurodevelopmental Outcome in preterm infants; EDD, expected date of delivery.

See this image and copyright information in PMC

References

1. Kerr-Wilson CO, Mackay DF, Smith GC et al. . Meta-analysis of the association between preterm delivery and intelligence. J Public Health (Oxford) 2012;34:209–16. 10.1093/pubmed/fdr024 - DOI - PubMed
1. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr 2007;137:855–9. - PubMed
1. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992;120:S129–38. 10.1016/S0022-3476(05)81247-8 - DOI - PubMed
1. Lapillonne A, Groh-Wargo S, Gonzalez CH et al. . Lipid needs of preterm infants: updated recommendations. J Pediatr 2013;162:S37–47. 10.1016/j.jpeds.2012.11.052 - DOI - PubMed
1. Henriksen C, Haugholt K, Lindgren M et al. . Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008;121:1137–45. 10.1542/peds.2007-1511 - DOI - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial

Affiliations

Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial

Authors

Affiliations

Abstract

Figures

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical